Bio-Rad Laboratories (NYSE:BIO) reported its Q4 earnings results on Thursday, February 15, 2024 at 04:15 PM.

Here's what investors need to know about the announcement.

Earnings

Bio-Rad Laboratories beat estimated earnings by 9.93%, reporting an EPS of $3.1 versus an estimate of $2.82.

Revenue was down $49.10 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.45 which was followed by a 7.15% drop in the share price the next day.

Here's a look at Bio-Rad Laboratories's past performance:

To track all earnings releases for Bio-Rad Laboratories visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.